BioNTech SE(BNTX)
$87.65+0.44 (+0.50%)
BNTX
BioNTech SE financials statements
$87.65
At close:+0.44 (+0.50%)
Want to see BNTX full AI Analyst Report?
BioNTech SE (BNTX) Ratios
4,926 Followers
BioNTech SE Ratios
BNTX's free cash flow for Q3 2026 was €-163.40M. For the 2026 fiscal year, BNTX's free cash flow was decreased by €-33.60M and operating cash flow was €-129.80M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 7.54 | 7.45 | 9.43 | 7.43 | 4.33 |
| Quick Ratio | 7.49 | 7.34 | 9.26 | 7.28 | 4.18 |
| Cash Ratio | 3.58 | 3.87 | 5.63 | 4.70 | 0.49 |
| Solvency Ratio | -0.26 | -0.12 | 0.40 | 2.97 | 2.63 |
| Operating Cash Flow Ratio | 0.20 | 0.08 | 2.59 | 4.60 | 0.26 |
| Short-Term Operating Cash Flow Coverage | 8.39 | 5.26 | 191.15 | 377.15 | 6.85 |
| Net Current Asset Value | € 13.38B | € 15.68B | € 16.77B | € 18.70B | € 11.14B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
| Debt-to-Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 |
| Debt-to-Capital Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
| Financial Leverage Ratio | 1.14 | 1.16 | 1.14 | 1.16 | 1.33 |
| Debt Service Coverage Ratio | -10.79 | -6.74 | 31.28 | 184.80 | 75.62 |
| Interest Coverage Ratio | -45.74 | -99.86 | 88.96 | 799.08 | 2715.05 |
| Debt to Market Cap | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
| Interest Debt Per Share | 1.16 | 1.11 | 0.94 | 0.94 | 1.26 |
| Net Debt to EBITDA | 11.79 | 25.90 | -8.31 | -1.04 | -0.09 |
| Profitability Margins | |||||
| Gross Profit Margin | 77.64% | 80.32% | 84.29% | 82.70% | 84.66% |
| EBIT Margin | -36.12% | -24.18% | 31.26% | 74.94% | 78.66% |
| EBITDA Margin | -22.78% | -13.34% | 36.07% | 75.65% | 79.06% |
| Operating Profit Margin | -22.63% | -47.77% | 18.08% | 73.03% | 80.54% |
| Pretax Profit Margin | -36.61% | -24.63% | 31.06% | 74.83% | 79.29% |
| Net Profit Margin | -39.59% | -24.18% | 24.36% | 54.50% | 54.24% |
| Continuous Operations Profit Margin | -39.59% | -24.18% | 24.36% | 54.50% | 54.24% |
| Net Income Per EBT | 108.12% | 98.17% | 78.43% | 72.83% | 68.41% |
| EBT Per EBIT | 161.79% | 51.56% | 171.80% | 102.46% | 98.45% |
| Return on Assets (ROA) | -4.96% | -2.95% | 4.04% | 40.53% | 65.02% |
| Return on Equity (ROE) | -5.68% | -3.43% | 4.60% | 47.04% | 86.54% |
| Return on Capital Employed (ROCE) | -3.14% | -6.57% | 3.30% | 62.19% | 123.76% |
| Return on Invested Capital (ROIC) | -3.14% | -6.44% | 2.58% | 45.21% | 83.78% |
| Return on Tangible Assets | -5.45% | -3.11% | 4.26% | 40.91% | 65.86% |
| Earnings Yield | -5.57% | -2.51% | 4.05% | 27.64% | 18.61% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.80 | 1.81 | 1.63 | 2.42 | 1.53 |
| Payables Turnover | 1.15 | 1.27 | 1.69 | 14.67 | 18.20 |
| Inventory Turnover | 5.57 | 1.91 | 1.68 | 6.81 | 5.79 |
| Fixed Asset Turnover | 2.14 | 2.32 | 3.93 | 21.08 | 36.47 |
| Asset Turnover | 0.13 | 0.12 | 0.17 | 0.74 | 1.20 |
| Working Capital Turnover Ratio | 0.18 | 0.16 | 0.21 | 1.13 | 3.00 |
| Cash Conversion Cycle | -120.70 | 105.49 | 225.87 | 179.38 | 281.10 |
| Days of Sales Outstanding | 130.35 | 202.18 | 223.62 | 150.68 | 238.16 |
| Days of Inventory Outstanding | 65.52 | 191.03 | 217.67 | 53.57 | 63.00 |
| Days of Payables Outstanding | 316.57 | 287.72 | 215.42 | 24.87 | 20.06 |
| Operating Cycle | 195.87 | 393.21 | 441.29 | 204.25 | 301.15 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.81 | 0.86 | 22.33 | 55.81 | 3.65 |
| Free Cash Flow Per Share | 1.12 | -1.02 | 19.39 | 54.31 | 3.02 |
| Dividend Paid and CapEx Coverage Ratio | 2.60 | 0.46 | 7.61 | 16.02 | 5.78 |
| Capital Expenditure Coverage Ratio | 2.60 | 0.46 | 7.61 | 37.37 | 5.78 |
| Operating Cash Flow Coverage Ratio | 1.64 | 0.82 | 24.52 | 63.98 | 2.95 |
| Operating Cash Flow to Sales Ratio | 0.16 | 0.08 | 1.41 | 0.78 | 0.05 |
| Free Cash Flow Yield | 1.38% | -0.92% | 20.31% | 38.71% | 1.33% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -17.97 | -39.76 | 24.69 | 3.62 | 5.37 |
| Price-to-Sales (P/S) Ratio | 7.10 | 9.62 | 6.02 | 1.97 | 2.91 |
| Price-to-Book (P/B) Ratio | 1.02 | 1.36 | 1.13 | 1.70 | 4.65 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 72.58 | -108.15 | 4.92 | 2.58 | 75.19 |
| Price-to-Operating Cash Flow Ratio | 44.71 | 127.37 | 4.28 | 2.51 | 62.17 |
| Price-to-Earnings Growth (PEG) Ratio | -0.29 | 0.23 | -0.27 | -0.27 | 0.00 |
| Enterprise Value Multiple | -19.39 | -46.16 | 8.37 | 1.56 | 3.59 |
| Enterprise Value | 12.18B | 16.95B | 11.53B | 20.47B | 53.93B |
| EV to EBITDA | -19.39 | -46.16 | 8.37 | 1.56 | 3.59 |
| EV to Sales | 4.42 | 6.16 | 3.02 | 1.18 | 2.84 |
| EV to Free Cash Flow | 45.14 | -69.28 | 2.47 | 1.55 | 73.30 |
| EV to Operating Cash Flow | 27.81 | 81.59 | 2.15 | 1.51 | 60.61 |
| Tangible Book Value Per Share | 71.34 | 75.87 | 79.30 | 81.53 | 47.92 |
| Shareholders’ Equity Per Share | 79.50 | 80.75 | 84.15 | 82.43 | 48.74 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.08 | 0.02 | 0.22 | 0.27 | 0.32 |
| Revenue Per Share | 11.41 | 11.44 | 15.87 | 71.15 | 77.77 |
| Net Income Per Share | -4.51 | -2.77 | 3.87 | 38.78 | 42.18 |
| Tax Burden | 1.08 | 0.98 | 0.78 | 0.73 | 0.68 |
| Interest Burden | 1.01 | 1.02 | 0.99 | 1.00 | 1.01 |
| Research & Development to Revenue | 0.73 | 0.82 | 0.47 | 0.09 | 0.05 |
| SG&A to Revenue | 0.25 | 0.22 | 0.13 | 0.03 | 0.01 |
| Stock-Based Compensation to Revenue | 0.00 | 0.04 | 0.01 | 0.01 | 0.00 |
| Income Quality | -0.40 | -0.31 | 4.53 | 1.05 | 0.06 |
Currency in EUR
